Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Post by jg75123on Oct 02, 2019 12:07pm

293 Views

Post# 30187548

Labs will do $150 - $200 Million is revenue next year.

This company is so undervalued at todays prices. with the amount of contracts in place and growing we are expected to do over $150 Million in revenue next year. giving a low 5X on that puts us at 750M market cap. today we are at 350M, if you put a 10X+ like most other stocks today then we are over $1B. which puts us at a $10 a share stock.

By Oct 2020 my prediction is we are a $10 stock.

safe money is investing in LABS

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal